Provides structured US market access for EvoLiver FDA-designated liver cancer surveillance test across health systems, payors and clinical stakeholders The ABHI programme will provide Mursla Bio with ...
The ABHI program will provide Mursla Bio with structured access to more than 300 senior healthcare leaders across 35 leading hospitals, 20 health systems, and US insurers. It also offers direct ...
The MarketWatch News Department was not involved in the creation of this content. Provides structured US market access for EvoLiver FDA-designated liver cancer surveillance test across health systems, ...
Provides structured US market access for EvoLiver FDA-designated liver cancer surveillance test across health systems, payors and clinical stakeholders Mursla Bio, a leader in Extracellular Vesicle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results